background_fid (1).jpg
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations

Neurontin

Michele Norris talks with NPR's Snigdha Prakash about actions by drug company Parke-Davis to promote the drug Neurontin for uses not yet approved by the government. NPR has obtained documents indicating that Tony Wild, then-president of Parke-Davis, was aware of the plan to work around FDA approval to promote the drug.

Copyright 2002 NPR

Snigdha Prakash
Pieces by National Desk reporter Snigdha Prakash can be heard on NPR's All Things Considered and Morning Edition. The majority of Snigdha's past reports have focused on topics related to entrepreneurship, business, banking and the economy.